Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

Two current and two former senior executives at AstraZeneca Plc are under investigation in China in an ongoing probe into ...

AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top ...

This is in addition to Leon Wang, the British drug maker’s China president, who remains in detention, an Astra spokesman told Bloomberg. The allegations of illegal importation relate to the movement ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

AstraZeneca stock tumbles as Chinese probe widens, implicating executives in insurance fraud and drug import violations ...

AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former executives of the company.

The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge ...

Two current and two former senior executives at AstraZeneca Plc are under investigation in China in an ongoing probe into alleged breaches of laws around drug importations and data privacy, the ...